Real-world evidence of the effect of adjunctive semaglutide on weight change, glycemic control, and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes
Source
Diabetes technology and therapeutics - ISSN 1520-9156-28:1 (2026) p. 27-37
SBP: always peritonitis in decompensated cirrhosis? Case report and review of the literature
Source
Acta gastro-enterologica belgica - ISSN 1784-3227-88:4 (2025) p. 361-365
Combination therapies for metabolic dysfunction-associated steatohepatitis : challenges and opportunities
Source
Gut : the journal of the British Society for Gastroenterology - ISSN 0017-5749- (2025) p.
Predictors of fibrosis, clinical events and mortality in MASLD : data from the Global-MASLD study
Source
Hepatology - ISSN 0270-9139- (2025) p.
Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
Source
Metabolism Open - ISSN 2589-9368-28 (2025) p. 1-12